{"ticker": {"uuid": "aa1276ec-49f8-4edd-bad0-db5c0c01133f", "symbol": "GOVX", "name": "GeoVax Labs Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "GeoVax Highlights Strategic Alignment of GEO-MVA With HHS/ASPR's Five-Year Medical Countermeasure Preparedness Strategy", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/geovax-highlights-strategic-alignment-geo-130000593.html", "source_name": "NewMediaWire", "published_at": "2026-07-21T13:00:00+00:00", "published_display": "21 Jul 2026 13:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNYmZ3aHMyMjBuNmlEUGN6NWZBZV85cEFWNndJaVNoNEVYNk84MlNKRXJ0RXpRQl9wN1RsekhxM3loY1RRNDJhTnVremtReHhLQWVHS053VzRBUTduSkdqRGt1YkxMMThqZHoydElPX1Zfd3hEMi15VlRwRGRvZ2JqRDFneVVxN0JCYzQ4QlV5TTBEOWx3?oc=5", "source_name": "Market source", "published_at": "2026-07-16T18:49:22+00:00", "published_display": "16 Jul 2026 18:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "GeoVax Labs(GOVX) Stock Options Chain | Quotes & News", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Moomoo", "published_at": "2026-07-13T12:07:14+00:00", "published_display": "13 Jul 2026 12:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T07:00:00+00:00", "published_display": "13 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "GeoVax Labs Faces Nasdaq Noncompliance and Listing Risk", "summary": "GeoVax Labs has received a notice from Nasdaq regarding noncompliance with its minimum stockholders' equity requirement, potentially leading to delisting. The company has 45 days to submit a compliance plan. This situation highlights GeoVax's financial strain and introduces uncer", "url": "https://www.theglobeandmail.com/investing/markets/stocks/GOVX/pressreleases/3240482/geovax-labs-faces-nasdaq-noncompliance-and-listing-risk/", "source_name": "The Globe and Mail", "published_at": "2026-07-12T17:09:48", "published_display": "12 Jul 2026 17:09", "sentiment": "negative", "sentiment_pct": 19, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GeoVax Labs | 8-K: Current report", "summary": "This document is an 8-K current report filed by GeoVax Labs with the SEC. It indicates that the full text of the report is available via a direct link to the SEC filing, and users may need to accept cookies to view it.", "url": "https://www.moomoo.com/news/notice/307700457/geovax-labs-8-k-current-report", "source_name": "Moomoo", "published_at": "2026-07-11T17:11:47", "published_display": "11 Jul 2026 17:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GEOVAX LABS INC (GOVX) Stock Chart", "summary": "", "url": "https://news.google.com/rss/articles/CBMiZEFVX3lxTE5NdzQxSzJuemhScjhDVGVMRzhDLVg2TS1vZ0hvOERSN3hPaXlwcV84VndNZWQ1UkVKTnJrUkJ0dl9rY2Y1dTBQcGRjbWU2b2FJbE5TRG1WZFNzcjdjamRNdU5wTXM?oc=5", "source_name": "ChartMill", "published_at": "2026-07-11T00:06:54+00:00", "published_display": "11 Jul 2026 00:06", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GeoVax Labs Received Notice of Noncompliance", "summary": "GeoVax Labs (GOVX) received a notice from Nasdaq on July 7, 2026, indicating noncompliance with the minimum stockholders' equity requirement of $2,500,000. The company has 45 days, until August 21, 2026, to submit a compliance plan. Trading of GOVX shares continues on Nasdaq.", "url": "https://www.tradingview.com/news/tradingview:13a8a6585ba49:0-geovax-labs-received-notice-of-noncompliance/", "source_name": "TradingView", "published_at": "2026-07-10T20:41:00", "published_display": "10 Jul 2026 20:41", "sentiment": "negative", "sentiment_pct": 28, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GeoVax Labs (NASDAQ: GOVX) flagged for Nasdaq $2.5M equity shortfall, delisting risk", "summary": "GeoVax Labs (NASDAQ: GOVX) received a notice from Nasdaq on July 7, 2026, indicating non-compliance with the $2.5 million minimum stockholders\u2019 equity requirement and alternative standards. The company has 45 calendar days, until August 21, 2026, to submit a compliance plan, with", "url": "https://www.stocktitan.net/sec-filings/GOVX/8-k-geo-vax-labs-inc-reports-material-event-3bc1f7538911.html", "source_name": "Stock Titan", "published_at": "2026-07-10T19:41:00", "published_display": "10 Jul 2026 19:41", "sentiment": "negative", "sentiment_pct": 8, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GeoVax Labs (GOVX) Stock Forecast & Analyst Ratings", "summary": "This article provides a stock forecast and analyst ratings for GeoVax Labs (GOVX). It includes information on the general consensus among analysts, price targets, and potential future performance of the company's stock.", "url": "https://www.moomoo.com/stock/GOVX-US/forecast?chain_id=Name1K9-3FXPhg.1l0klk0&global_content=%7B%22promote_id%22%3A13764,%22sub_promote_id%22%3A109,%22f%22%3A%22www.moomoo.com%2Fsectors%2FTechnology-BK20763%22%7D", "source_name": "Moomoo", "published_at": "2026-07-09T03:41:00", "published_display": "09 Jul 2026 03:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GeoVax Highlights Continued U.S. Government Investment in Orthopox Preparedness as Strategic Validation of Long-Term Vaccine Readiness", "summary": "GeoVax Labs, Inc. commented on the U.S. government's recent procurement of additional ACAM2000(R) smallpox vaccine, interpreting it as ongoing strategic validation of long-term vaccine readiness and investment in orthopoxvirus preparedness. The company views this continued federa", "url": "https://finance.yahoo.com/healthcare/articles/geovax-highlights-continued-u-government-130000445.html", "source_name": "Market source", "published_at": "2026-07-02T01:12:58", "published_display": "02 Jul 2026 01:12", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of GeoVax Labs, Inc. \u2013 NASDAQ:GOVX", "summary": "This page from TradingView provides financial information for GeoVax Labs, Inc. (NASDAQ: GOVX), specifically focusing on its price-to-earnings forward metric. The content appears to be a financial data presentation rather than an analytical article, showing market data and naviga", "url": "https://www.tradingview.com/symbols/NASDAQ-GOVX/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-07-01T18:08:44", "published_display": "01 Jul 2026 18:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GeoVax Labs (GOVX) Stock Fair Value Moves Lower After Pipeline Shift", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxPTXpxN1dVUFpHS1loSC1HNGxLbERVV1l5QVR5UU5xa0dYQUhaVUNzanZQcE1ia1haMzFER2JNR0w0Q25nTDRsaFR6WHBvY0Vwb0g5d3UwNmJqMFgzUHVSZ0o3WTI1cmc0T3FDR041SDlvN3FfbTRrd0I4Tm9CNkYwc3VWZ0gtSFk3R3J0VGEyUlQ3c1VmcmM4?oc=5", "source_name": "Market source", "published_at": "2026-06-27T07:00:00+00:00", "published_display": "27 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GeoVax Labs, Inc. Actuals & Estimates (NASDAQ:GOVX)", "summary": "This article provides an overview of GeoVax Labs, Inc. (NASDAQ: GOVX) stock, including its current price, market capitalization, and historical performance. It also details analyst forecasts, past earnings, and upcoming financial reporting dates for the biotechnology company. The", "url": "https://www.tradingview.com/symbols/NASDAQ-GOVX/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T10:39:51", "published_display": "26 Jun 2026 10:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of GeoVax Labs, Inc. \u2013 NASDAQ:GOVX", "summary": "This article provides financial data for GeoVax Labs, Inc. (NASDAQ: GOVX), specifically focusing on its forward price-to-sales ratio. It indicates that the company's financial information, including period value, change, and percentage change, is available, likely through the Tra", "url": "https://www.tradingview.com/symbols/NASDAQ-GOVX/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-25T03:42:35", "published_display": "25 Jun 2026 03:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[Form 4] GeoVax Labs, Inc. Insider Trading Activity", "summary": "GeoVax Labs, Inc. reported insider trading activity where Chief Medical Officer Kelly T. McKee Jr. received a grant of 17,600 stock options, exercisable at $1.18 per share. These options vest in three equal annual installments and expire on June 17, 2036. Following this transacti", "url": "https://www.stocktitan.net/sec-filings/GOVX/form-4-geo-vax-labs-inc-insider-trading-activity-bef6a296a9c4.html", "source_name": "Stock Titan", "published_at": "2026-06-24T12:40:19", "published_display": "24 Jun 2026 12:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 GeoVax Labs Inc For: 22 June By Investing.com", "summary": "This article from Investing.com simply announces a Form 4 filing for GeoVax Labs Inc. on June 22nd. It does not provide any further details about the content of the filing or its implications. The article primarily consists of navigational elements and market data, typical of a f", "url": "https://za.investing.com/news/stock-market-news/form-4-geovax-labs-inc-for-22-june-93CH-4338537", "source_name": "Investing.com South Africa", "published_at": "2026-06-23T10:10:50", "published_display": "23 Jun 2026 10:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Director at GeoVax (GOVX) receives 6,000-share stock option grant", "summary": "GeoVax Labs, Inc. director Randal D. Chase was granted 6,000 stock options with an exercise price of $1.18 per share. These options become exercisable on June 17, 2027, and will expire on June 17, 2036. This transaction is a grant and not an open-market purchase or sale of existi", "url": "https://www.stocktitan.net/sec-filings/GOVX/form-4-geo-vax-labs-inc-insider-trading-activity-093987a41cbc.html", "source_name": "Stock Titan", "published_at": "2026-06-23T10:10:50", "published_display": "23 Jun 2026 10:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GeoVax Labs (GOVX) CFO awarded 17,600 stock options in new grant", "summary": "GeoVax Labs' CFO, Mark Reynolds, was granted 17,600 stock options with an exercise price of $1.18 per share. These options, expiring on June 17, 2036, will become exercisable in three equal annual installments on the first three anniversaries of the grant date, as reported in a F", "url": "https://www.stocktitan.net/sec-filings/GOVX/form-4-geo-vax-labs-inc-insider-trading-activity-3a9affbbf86d.html", "source_name": "Stock Titan", "published_at": "2026-06-23T09:39:32", "published_display": "23 Jun 2026 09:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GeoVax (GOVX) director awarded 6,000 stock options at $1.18 strike", "summary": "GeoVax Labs, Inc. director Robert T. McNally was granted 6,000 stock options with an exercise price of $1.18 per share. These options become exercisable on June 17, 2027, and have an expiration date of June 17, 2036. This transaction was a compensation-related award and not an op", "url": "https://www.stocktitan.net/sec-filings/GOVX/form-4-geo-vax-labs-inc-insider-trading-activity-2fc0893772d2.html", "source_name": "Stock Titan", "published_at": "2026-06-23T09:39:31", "published_display": "23 Jun 2026 09:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GeoVax (GOVX) director awarded 6,000 stock options at $1.18 exercise price", "summary": "GeoVax Labs, Inc. director Morgan Jayne was granted 6,000 stock options with an exercise price of $1.18 per share. These options become exercisable on June 17, 2027, and are set to expire on June 17, 2036. This transaction is categorized as a compensation-related award of derivat", "url": "https://www.stocktitan.net/sec-filings/GOVX/form-4-geo-vax-labs-inc-insider-trading-activity-c324c89b6d86.html", "source_name": "Stock Titan", "published_at": "2026-06-22T22:10:28", "published_display": "22 Jun 2026 22:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GeoVax (GOVX) director receives 6,000 stock options at $1.18 strike", "summary": "GeoVax Labs, Inc. director John N. Spencer Jr has been granted 6,000 stock options with an exercise price of $1.18 per share. These options become exercisable on June 17, 2027, and have an expiration date of June 17, 2036. This transaction is categorized as an acquisition of deri", "url": "https://www.stocktitan.net/sec-filings/GOVX/form-4-geo-vax-labs-inc-insider-trading-activity-da844cad0b13.html", "source_name": "Stock Titan", "published_at": "2026-06-22T22:10:28", "published_display": "22 Jun 2026 22:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GeoVax Labs (GOVX) director gets grant of 6,000 stock options", "summary": "GeoVax Labs director Dean G. Kollintzas was granted 6,000 stock options on June 17, 2026. These options have an exercise price of $1.18 per share and expire on June 17, 2036. This transaction is categorized as a compensation-related award, not a market purchase, increasing his de", "url": "https://www.stocktitan.net/sec-filings/GOVX/form-4-geo-vax-labs-inc-insider-trading-activity-1892f0278ead.html", "source_name": "Stock Titan", "published_at": "2026-06-22T21:40:33", "published_display": "22 Jun 2026 21:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GeoVax (GOVX) CEO David Dodd granted 29,300 stock options at $1.18 strike", "summary": "GeoVax Labs, Inc. President and CEO David A. Dodd was granted 29,300 stock options with an exercise price of $1.18 per share. These options, which expire on June 17, 2036, will vest in three equal annual installments on the first three anniversaries of the grant date. This transa", "url": "https://www.stocktitan.net/sec-filings/GOVX/form-4-geo-vax-labs-inc-insider-trading-activity-8ba1ccfcda57.html", "source_name": "Stock Titan", "published_at": "2026-06-22T20:10:09", "published_display": "22 Jun 2026 20:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GeoVax Labs (GOVX) VP receives grant of 17,600 stock options", "summary": "GeoVax Labs, Inc. (GOVX) VP of Business Development, John W. Sharkey, received a grant of 17,600 stock options on June 17, 2026. These options have an exercise price of $1.18 per share and will vest in three equal annual installments, expiring on June 17, 2036. This transaction i", "url": "https://www.stocktitan.net/sec-filings/GOVX/form-4-geo-vax-labs-inc-insider-trading-activity-c9a631603814.html", "source_name": "Stock Titan", "published_at": "2026-06-22T20:10:09", "published_display": "22 Jun 2026 20:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Director at GeoVax Labs (NASDAQ: GOVX) granted 6,000 options", "summary": "GeoVax Labs director Nicole Lemerond was granted 6,000 stock options, which allow her to purchase common stock at an exercise price of $1.18 per share, with an expiration date of June 17, 2036. This transaction is classified as a routine equity compensation award, not an open-mar", "url": "https://www.stocktitan.net/sec-filings/GOVX/form-4-geo-vax-labs-inc-insider-trading-activity-e22db6dea669.html", "source_name": "Stock Titan", "published_at": "2026-06-22T20:10:09", "published_display": "22 Jun 2026 20:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GeoVax Labs Inc (GOVX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "This article from TradingKey attempts to provide a revenue breakdown for GeoVax Labs Inc (GOVX) by business segments and regions. However, it explicitly states that the relevant financial data has not yet been disclosed by the company, making a detailed analysis impossible at thi", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-govx/revenue", "source_name": "TradingKey", "published_at": "2026-06-18T19:39:49", "published_display": "18 Jun 2026 19:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GeoVax Labs Inc (GOVX) Institutional Confidence", "summary": "This article provides an overview of institutional confidence in GeoVax Labs Inc (GOVX), highlighting key shareholders and their holdings. The company's stock information, including its recent price and market capitalization, is also presented, alongside a breakdown of various fi", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-govx/sentiment", "source_name": "TradingKey", "published_at": "2026-06-18T19:39:48", "published_display": "18 Jun 2026 19:39", "sentiment": "positive", "sentiment_pct": 77, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GeoVax Labs Inc (GOVX) Shareholder Structure: Major Shareholders & Institutional Holdings", "summary": "This article provides an overview of GeoVax Labs Inc.'s (GOVX) shareholder structure, detailing major institutional shareholders and their holdings. It lists top shareholders like Citadel Advisors LLC and Renaissance Technologies LLC, along with various shareholder types and thei", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-govx/ownership", "source_name": "TradingKey", "published_at": "2026-06-18T03:09:20", "published_display": "18 Jun 2026 03:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GeoVax Labs Inc (GOVX) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "This article provides an overview of GeoVax Labs Inc (GOVX) dividend and stock split history. It notes that the company has distributed $0.00 in dividends over the past five years and lists several stock merger events from January 2024 and one scheduled for January 2026. The data", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-govx/dividend-splits", "source_name": "TradingKey", "published_at": "2026-06-18T02:09:19", "published_display": "18 Jun 2026 02:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GeoVax Labs Inc (GOVX) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "GeoVax Labs Inc (GOVX) has an earnings forecast score of 7.33, ranking 295th in its industry. Analysts have set an average price target of $8.50, with a consensus \"Buy\" rating based on two analysts. The company's EPS for the last quarter was -$2.55, better than the market expecta", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-govx/earnings", "source_name": "TradingKey", "published_at": "2026-06-17T20:09:20", "published_display": "17 Jun 2026 20:09", "sentiment": "positive", "sentiment_pct": 72, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GeoVax Labs (GOVX) shareholders approve major warrant share issuances and governance items", "summary": "GeoVax Labs shareholders have approved several key items at their recent annual meeting, including the election of seven directors, ratification of Wipfli LLP as the independent auditor for 2026, and advisory approval of executive compensation with future say-on-pay votes every t", "url": "https://www.stocktitan.net/sec-filings/GOVX/8-k-geo-vax-labs-inc-reports-material-event-58711287cf03.html", "source_name": "Stock Titan", "published_at": "2026-06-17T20:09:19", "published_display": "17 Jun 2026 20:09", "sentiment": "negative", "sentiment_pct": 30, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GeoVax Highlights Strategic Implications of Recent Gedeptin(R) Findings for Checkpoint-Resistant Cancers", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/geovax-highlights-strategic-implications-recent-130000583.html", "source_name": "NewMediaWire", "published_at": "2026-06-17T13:00:00+00:00", "published_display": "17 Jun 2026 13:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GeoVax Labs Inc (GOVXW) Institutional Confidence", "summary": "This article provides details on the institutional confidence for GeoVax Labs Inc (GOVXW), focusing on institutional shareholding and shareholder activity. It lists UBS Financial Services, Inc. and Clear Street LLC as notable shareholders with their respective shares held and per", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-govxw/sentiment", "source_name": "TradingKey", "published_at": "2026-06-17T09:40:35", "published_display": "17 Jun 2026 09:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GeoVax Labs (GOVX) Could Find a Support Soon, Here's Why You Should Buy the Stock Now", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxQUnV6cFZGSk9MZFg5WjhTdkdyRWNHdXhQel9qZmtCbVROYkljaUNXbDYtX05mZGdrSDJBdFhFdDlxOTFEcmJ6QkhMVzhfbFlEbG1XdzdYRlpOSHlPV2t3VlBJU3VMRVlIbklSRE5haGJVekhJRnI0NzJIaGdVcmc1LUdPbkpLTGNFLUxaSE9ZdndXeTB5ekFNYVhlcw?oc=5", "source_name": "Market source", "published_at": "2026-06-12T07:00:00+00:00", "published_display": "12 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GeoVax Highlights Peer-Reviewed Research Supporting Gedeptin(R) Potential to Enhance Cancer Immunotherapy Responses", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/geovax-highlights-peer-reviewed-research-130000933.html", "source_name": "NewMediaWire", "published_at": "2026-06-08T13:00:00+00:00", "published_display": "08 Jun 2026 13:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GeoVax CEO Highlights Renewed Strategic Interest in Vaccine Platforms and Infectious Disease Innovation", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/geovax-ceo-highlights-renewed-strategic-130000780.html", "source_name": "NewMediaWire", "published_at": "2026-06-03T13:00:00+00:00", "published_display": "03 Jun 2026 13:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GeoVax CEO Welcomes FIFA World Cup 2026 While Addressing Biothreat Readiness", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/geovax-ceo-welcomes-fifa-world-131500641.html", "source_name": "NewMediaWire", "published_at": "2026-06-01T13:15:00+00:00", "published_display": "01 Jun 2026 13:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How The GeoVax Labs (GOVX) Story Is Shifting With Vaccine Progress And Funding Risks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOSHVULTdZVTQ2YkNUMUluYWtIdEdMSGwtQTFUbkg4bEpQWXdaa0dVMG5qOVVSWndEazZLbmh0WlliejhodlhwZnA3RmwxckFNUVhwSXZBQmQ4MW9xcUFZaW9VQXhlREpUY1JYdzhTOGc1VTlnQlVYMk00WDB5dGFVb0VZMUpMNWhCeEtDS1BMX25tbnEtTGpSVDl3U1g?oc=5", "source_name": "Market source", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GeoVax (NASDAQ: GOVX) prices $3M warrant-based private financing", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxNdEFQdVBYQXQ0NWNpeDhWYzBfNUllUndiQzhDcm9VMU9DU0NVdTdVczdaQjdMRUdBdmV5UGMzSFVPN1hCUFdiRTNEWjBiQVllZTBoblduN3ZlMVFzakFSWHVxMkJmV1c3SzB0M1FJMzZrVlR6UnJGVnVRVDVvanpPTW55bGRxZTZsV0xJekNOSWktTW54dFZ1SzlkeFg0NGN0bGZRc2RvX1c?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-19T07:00:00+00:00", "published_display": "19 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Is GeoVax Labs Stock Falling Tuesday?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxPcmZFNllrOEd0T2l5dEJaSG0wandOc0EzaEloekRENEhsUFNsS25JbWx5Ti12MlhmMWgxVmI3T0pXTjZmcmRkODhObFhnZU5OazZaQnFDUmIzOXdBZHNST19QdTVmUXVNNmdQT2h2TVp3NEhKM0ZXZk1mWGpfQ2xtR2hrMXlIeXF3dkdRWDZRZndKalRIQS1EQWY3ZTczYUVfR0g4?oc=5", "source_name": "Benzinga", "published_at": "2026-05-19T07:00:00+00:00", "published_display": "19 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GeoVax Announces $3 Million Private Placement Financing Priced At-the-Market Under Nasdaq Rules", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNMndZdlVjMjd6ZjNFRFhyWklxNlJibDRTTXFIQzBvU0VpX1BQdXV5VGVOcmMxaWpqcnFPdm9DRVQxWWphNzU2SHVkVDVBOHRYS1kwNDJqcDI1VG41cHl1MnpSRVY4alB2aFVkMGdKM1daS3hMbFNuUWpYTldDQnJIeHRwMU9FQmRWY0o1VDVNdExtYkpicU1uMzRxc0VuYVhzUXFGbmFR?oc=5", "source_name": "Market source", "published_at": "2026-05-18T07:00:00+00:00", "published_display": "18 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GeoVax Labs (GOVX) jumps 178% as traders refocus on mpox vaccine thesis after recent Q1 update", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxNZzYwTmFiYi1BSjJrb0hTSi0xNUhWZG9kb1UyMVJ4TDJadkVTZXNJelhuTTRGYWlSWmFMdVFZYXlEclduZ0toVDRLdEpPMUk4ZGhMZ3E5REJTZjF5T0V4UkFOTW5iX1IwVzRFakJLeHFsVllQalp0WjRpTFp4TUFWbHdjaFpGaU5CNllpdV9NRU9yWUw0eDFzaDdISFVGcUNaV3pKbWtVMFdXTWE3ODR2YnVOOS1fNGY5T1V2TWVFb1pwWEstajVlTkwyUUJUZw?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-05-18T07:00:00+00:00", "published_display": "18 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "All You Need to Know About GeoVax Labs (GOVX) Rating Upgrade to Buy", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxOQWZEcHlNSGhKeWZRcTFrLUI4VVBNdWM3R0JaMkwxTjAzVzBJUXE2UU8yMnJqTVNjb091SzBpX2ZsSnk2MkJPdVU2YVAzQWloZGF1VUU1RGtlczZzcWRESmEtaDl2ekJmOVFaanpRMldTcHlMblVfVG96d3dnWkRLSEI0RmRIcW9MMWV5SFRNOGFCX04yOHBQZg?oc=5", "source_name": "Market source", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "GeoVax Announces a Warrant Inducement Transaction", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxOQldhNkJWUTZudzRkWjhGaUd3YXFkalR0TE4wcF9WR2FkSnl4Q2NoemRqZnBqOVEyRGZGMF9nNktKRzlHWXdJbWFHMHdYU09qejdNSlBEemFJRGFkampNQmc2czlSRjNUVnB2dEZ0czdWbF9BR0c0UnFqbi1sankySmcyRGpPdzhSSEgzbFh1QWtXZHRha3FJdDZlOGNfQVIxRG9KSGdleUkzMS15Nnp6U1NkMEtYTFU?oc=5", "source_name": "Market source", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "How The GeoVax Labs (GOVX) Story Is Shifting After The Rating Downgrade And Valuation Reset", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxNNFViVGlvY21mbHJFSV9RWGFqdUVFODBNSVV4SHNiLWZHMkJrQmgzeUhUWWZ3S1hObVpEMnNHT214LUVZZTdaR1FTRFZTanNoN3E0MVk1Snk3MlE0RndoN3FyUDdmd1haaTBROThiQ3N2bDl0aTJ1dzVjQlk4OGtBUWRCd1BobllPSXZTSm9rWVNDTlQ0bkp4eldnQVE?oc=5", "source_name": "Market source", "published_at": "2026-04-14T07:00:00+00:00", "published_display": "14 Apr 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why The GeoVax Labs (GOVX) Story Is Shifting As Valuation Holds And Risks Rise", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxOdGFTS1U5dzFPUHd4VlJaeDYtQzVFaUlYa1pCTW1MQkFNdlJFeWxYeTIxMjBQWmVDWlMyZzNvQ3dyWTVxY3JueW5vdXRnUnNSbkF6bE1XZzUybXl3Z01kNzJUZy1SN0VKUUQ5MDZaUGdDbTJmcmNUTG1UdGp4dUY0RUJ0RkliVXdfbXdPY2dHS0tSZUxoY3c?oc=5", "source_name": "Market source", "published_at": "2026-03-31T07:00:00+00:00", "published_display": "31 Mar 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "How The Story On GeoVax Labs (GOVX) Is Shifting Toward Execution Risk And Funding Constraints", "summary": "", "url": "https://news.google.com/rss/articles/CBMigwFBVV95cUxPX1BJcWJCclFDaGhwRXFKY1RfOXU5YjBfZHhFbHhReXE1c0NkTGEyVzZDR29fRmlpVXRBZGFOcEx5N09XU09HRmhUclhrdXZOZkZ1bXZTUDdRUHQtVmZ4UFQtOE1WMHhoOWN0NHBvOFIwaUNHOUNYbFVvT2xXcU0zcXJBOA?oc=5", "source_name": "Market source", "published_at": "2026-03-11T07:00:00+00:00", "published_display": "11 Mar 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GeoVax Announces 1-for-25 Reverse Stock Split to Regain Compliance With Nasdaq Minimum Bid Requirement", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxQVFFHUVNhWjhscjlZNEFoY2Jra0tmM3ItZVhrRDhJUFBObW9rZEFXLW1aS3VvR1l2SFpXWXpLOHRKRk5tN1JuSHNYWE80MFZ3cWhnWXJDRFdFVUVBd3ZFR2oyUVV1UGlSU1BoM2ZieGE3T3h2bjZfOEtRX0V1Y1hfQQ?oc=5", "source_name": "Market source", "published_at": "2026-01-08T08:00:00+00:00", "published_display": "08 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GeoVax Labs, Inc. (GOVX) Stock Price Quote Today & Current Price Chart", "summary": "", "url": "https://news.google.com/rss/articles/CBMie0FVX3lxTE1SUHBETm9JLVpTSHVpLXBlTFdNcGJDR1hjemZkNHNJMXllVXVOdW5PNXdHSU0tUFpMRGxtR18tcnEwM0lkZkJ1MTVPLXZaNmhDNXh3LXVIZWFka3dwem5SU2EyV1cxVDJYaVVRQ0k2dWJwNmc3YnBYSjNnQQ?oc=5", "source_name": "Capital.com", "published_at": "2025-11-13T06:11:30+00:00", "published_display": "13 Nov 2025 06:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Geovax Labs (GOVX) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE1BS01TYVUtZ09DSktOZlZsSC12MGo4MFpna3V3VjdOMUVvZlp5U29lUjJxYTI0MzZnaEkwQXh3aFcxeURUbjlUUTl6YUh2WWJpbHl3?oc=5", "source_name": "Stock Titan", "published_at": "2025-04-25T00:20:37+00:00", "published_display": "25 Apr 2025 00:20", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Geovax Labs (GOVXW) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiVEFVX3lxTE1LZGxVZkhvLThmNHFsZU54MHp0R253TW41d3V0N1dIRUZSRE83dVdfaUtfV0NQSmhZUENzMDF6YmZ4VW10bGdET0FHajQ1bGlpV01mTw?oc=5", "source_name": "Stock Titan", "published_at": "2025-04-25T00:19:17+00:00", "published_display": "25 Apr 2025 00:19", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GeoVax Labs, Inc. (GOVX): A Hot Penny Stock On The Move", "summary": "", "url": "https://news.google.com/rss/articles/CBMiekFVX3lxTE5jUy0wcnBfWURUMk9KU0pJWm5ZZk9rQkdYM2hfVTBfZTFNMzJOQ3l4YU5JWGI5VFlvaXlxTWRGdXJNLXdKYV9OWWNGTTB1TWowR21aa254SU1DS2NuTDltWjRvYmhHUWNndWVFX3hWREhVM0w4QkpxNnhn?oc=5", "source_name": "Market source", "published_at": "2024-09-03T07:00:00+00:00", "published_display": "03 Sep 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "GeoVax Highlights Strategic Alignment of GEO-MVA With HHS/ASPR's Five-Year Medical Countermeasure Preparedness Strategy", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/geovax-highlights-strategic-alignment-geo-130000593.html", "source_name": "NewMediaWire", "published_at": "2026-07-21T13:00:00+00:00", "published_display": "21 Jul 2026 13:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GeoVax Labs(GOVX) Stock Options Chain | Quotes & News", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Moomoo", "published_at": "2026-07-13T12:07:14+00:00", "published_display": "13 Jul 2026 12:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GeoVax Labs Faces Nasdaq Noncompliance and Listing Risk", "summary": "GeoVax Labs has received a notice from Nasdaq regarding noncompliance with its minimum stockholders' equity requirement, potentially leading to delisting. The company has 45 days to submit a compliance plan. This situation highlights GeoVax's financial strain and introduces uncer", "url": "https://www.theglobeandmail.com/investing/markets/stocks/GOVX/pressreleases/3240482/geovax-labs-faces-nasdaq-noncompliance-and-listing-risk/", "source_name": "The Globe and Mail", "published_at": "2026-07-12T17:09:48", "published_display": "12 Jul 2026 17:09", "sentiment": "negative", "sentiment_pct": 19, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GeoVax Labs | 8-K: Current report", "summary": "This document is an 8-K current report filed by GeoVax Labs with the SEC. It indicates that the full text of the report is available via a direct link to the SEC filing, and users may need to accept cookies to view it.", "url": "https://www.moomoo.com/news/notice/307700457/geovax-labs-8-k-current-report", "source_name": "Moomoo", "published_at": "2026-07-11T17:11:47", "published_display": "11 Jul 2026 17:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GEOVAX LABS INC (GOVX) Stock Chart", "summary": "", "url": "https://news.google.com/rss/articles/CBMiZEFVX3lxTE5NdzQxSzJuemhScjhDVGVMRzhDLVg2TS1vZ0hvOERSN3hPaXlwcV84VndNZWQ1UkVKTnJrUkJ0dl9rY2Y1dTBQcGRjbWU2b2FJbE5TRG1WZFNzcjdjamRNdU5wTXM?oc=5", "source_name": "ChartMill", "published_at": "2026-07-11T00:06:54+00:00", "published_display": "11 Jul 2026 00:06", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GeoVax Labs Received Notice of Noncompliance", "summary": "GeoVax Labs (GOVX) received a notice from Nasdaq on July 7, 2026, indicating noncompliance with the minimum stockholders' equity requirement of $2,500,000. The company has 45 days, until August 21, 2026, to submit a compliance plan. Trading of GOVX shares continues on Nasdaq.", "url": "https://www.tradingview.com/news/tradingview:13a8a6585ba49:0-geovax-labs-received-notice-of-noncompliance/", "source_name": "TradingView", "published_at": "2026-07-10T20:41:00", "published_display": "10 Jul 2026 20:41", "sentiment": "negative", "sentiment_pct": 28, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GeoVax Labs (NASDAQ: GOVX) flagged for Nasdaq $2.5M equity shortfall, delisting risk", "summary": "GeoVax Labs (NASDAQ: GOVX) received a notice from Nasdaq on July 7, 2026, indicating non-compliance with the $2.5 million minimum stockholders\u2019 equity requirement and alternative standards. The company has 45 calendar days, until August 21, 2026, to submit a compliance plan, with", "url": "https://www.stocktitan.net/sec-filings/GOVX/8-k-geo-vax-labs-inc-reports-material-event-3bc1f7538911.html", "source_name": "Stock Titan", "published_at": "2026-07-10T19:41:00", "published_display": "10 Jul 2026 19:41", "sentiment": "negative", "sentiment_pct": 8, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GeoVax Labs (GOVX) Stock Forecast & Analyst Ratings", "summary": "This article provides a stock forecast and analyst ratings for GeoVax Labs (GOVX). It includes information on the general consensus among analysts, price targets, and potential future performance of the company's stock.", "url": "https://www.moomoo.com/stock/GOVX-US/forecast?chain_id=Name1K9-3FXPhg.1l0klk0&global_content=%7B%22promote_id%22%3A13764,%22sub_promote_id%22%3A109,%22f%22%3A%22www.moomoo.com%2Fsectors%2FTechnology-BK20763%22%7D", "source_name": "Moomoo", "published_at": "2026-07-09T03:41:00", "published_display": "09 Jul 2026 03:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GeoVax Highlights Continued U.S. Government Investment in Orthopox Preparedness as Strategic Validation of Long-Term Vaccine Readiness", "summary": "GeoVax Labs, Inc. commented on the U.S. government's recent procurement of additional ACAM2000(R) smallpox vaccine, interpreting it as ongoing strategic validation of long-term vaccine readiness and investment in orthopoxvirus preparedness. The company views this continued federa", "url": "https://finance.yahoo.com/healthcare/articles/geovax-highlights-continued-u-government-130000445.html", "source_name": "Market source", "published_at": "2026-07-02T01:12:58", "published_display": "02 Jul 2026 01:12", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of GeoVax Labs, Inc. \u2013 NASDAQ:GOVX", "summary": "This page from TradingView provides financial information for GeoVax Labs, Inc. (NASDAQ: GOVX), specifically focusing on its price-to-earnings forward metric. The content appears to be a financial data presentation rather than an analytical article, showing market data and naviga", "url": "https://www.tradingview.com/symbols/NASDAQ-GOVX/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-07-01T18:08:44", "published_display": "01 Jul 2026 18:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GeoVax Labs (GOVX) Stock Fair Value Moves Lower After Pipeline Shift", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxPTXpxN1dVUFpHS1loSC1HNGxLbERVV1l5QVR5UU5xa0dYQUhaVUNzanZQcE1ia1haMzFER2JNR0w0Q25nTDRsaFR6WHBvY0Vwb0g5d3UwNmJqMFgzUHVSZ0o3WTI1cmc0T3FDR041SDlvN3FfbTRrd0I4Tm9CNkYwc3VWZ0gtSFk3R3J0VGEyUlQ3c1VmcmM4?oc=5", "source_name": "Market source", "published_at": "2026-06-27T07:00:00+00:00", "published_display": "27 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GeoVax Labs, Inc. Actuals & Estimates (NASDAQ:GOVX)", "summary": "This article provides an overview of GeoVax Labs, Inc. (NASDAQ: GOVX) stock, including its current price, market capitalization, and historical performance. It also details analyst forecasts, past earnings, and upcoming financial reporting dates for the biotechnology company. The", "url": "https://www.tradingview.com/symbols/NASDAQ-GOVX/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T10:39:51", "published_display": "26 Jun 2026 10:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of GeoVax Labs, Inc. \u2013 NASDAQ:GOVX", "summary": "This article provides financial data for GeoVax Labs, Inc. (NASDAQ: GOVX), specifically focusing on its forward price-to-sales ratio. It indicates that the company's financial information, including period value, change, and percentage change, is available, likely through the Tra", "url": "https://www.tradingview.com/symbols/NASDAQ-GOVX/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-25T03:42:35", "published_display": "25 Jun 2026 03:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[Form 4] GeoVax Labs, Inc. Insider Trading Activity", "summary": "GeoVax Labs, Inc. reported insider trading activity where Chief Medical Officer Kelly T. McKee Jr. received a grant of 17,600 stock options, exercisable at $1.18 per share. These options vest in three equal annual installments and expire on June 17, 2036. Following this transacti", "url": "https://www.stocktitan.net/sec-filings/GOVX/form-4-geo-vax-labs-inc-insider-trading-activity-bef6a296a9c4.html", "source_name": "Stock Titan", "published_at": "2026-06-24T12:40:19", "published_display": "24 Jun 2026 12:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 GeoVax Labs Inc For: 22 June By Investing.com", "summary": "This article from Investing.com simply announces a Form 4 filing for GeoVax Labs Inc. on June 22nd. It does not provide any further details about the content of the filing or its implications. The article primarily consists of navigational elements and market data, typical of a f", "url": "https://za.investing.com/news/stock-market-news/form-4-geovax-labs-inc-for-22-june-93CH-4338537", "source_name": "Investing.com South Africa", "published_at": "2026-06-23T10:10:50", "published_display": "23 Jun 2026 10:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Director at GeoVax (GOVX) receives 6,000-share stock option grant", "summary": "GeoVax Labs, Inc. director Randal D. Chase was granted 6,000 stock options with an exercise price of $1.18 per share. These options become exercisable on June 17, 2027, and will expire on June 17, 2036. This transaction is a grant and not an open-market purchase or sale of existi", "url": "https://www.stocktitan.net/sec-filings/GOVX/form-4-geo-vax-labs-inc-insider-trading-activity-093987a41cbc.html", "source_name": "Stock Titan", "published_at": "2026-06-23T10:10:50", "published_display": "23 Jun 2026 10:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GeoVax Labs (GOVX) CFO awarded 17,600 stock options in new grant", "summary": "GeoVax Labs' CFO, Mark Reynolds, was granted 17,600 stock options with an exercise price of $1.18 per share. These options, expiring on June 17, 2036, will become exercisable in three equal annual installments on the first three anniversaries of the grant date, as reported in a F", "url": "https://www.stocktitan.net/sec-filings/GOVX/form-4-geo-vax-labs-inc-insider-trading-activity-3a9affbbf86d.html", "source_name": "Stock Titan", "published_at": "2026-06-23T09:39:32", "published_display": "23 Jun 2026 09:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GeoVax (GOVX) director awarded 6,000 stock options at $1.18 strike", "summary": "GeoVax Labs, Inc. director Robert T. McNally was granted 6,000 stock options with an exercise price of $1.18 per share. These options become exercisable on June 17, 2027, and have an expiration date of June 17, 2036. This transaction was a compensation-related award and not an op", "url": "https://www.stocktitan.net/sec-filings/GOVX/form-4-geo-vax-labs-inc-insider-trading-activity-2fc0893772d2.html", "source_name": "Stock Titan", "published_at": "2026-06-23T09:39:31", "published_display": "23 Jun 2026 09:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GeoVax (GOVX) director awarded 6,000 stock options at $1.18 exercise price", "summary": "GeoVax Labs, Inc. director Morgan Jayne was granted 6,000 stock options with an exercise price of $1.18 per share. These options become exercisable on June 17, 2027, and are set to expire on June 17, 2036. This transaction is categorized as a compensation-related award of derivat", "url": "https://www.stocktitan.net/sec-filings/GOVX/form-4-geo-vax-labs-inc-insider-trading-activity-c324c89b6d86.html", "source_name": "Stock Titan", "published_at": "2026-06-22T22:10:28", "published_display": "22 Jun 2026 22:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GeoVax (GOVX) director receives 6,000 stock options at $1.18 strike", "summary": "GeoVax Labs, Inc. director John N. Spencer Jr has been granted 6,000 stock options with an exercise price of $1.18 per share. These options become exercisable on June 17, 2027, and have an expiration date of June 17, 2036. This transaction is categorized as an acquisition of deri", "url": "https://www.stocktitan.net/sec-filings/GOVX/form-4-geo-vax-labs-inc-insider-trading-activity-da844cad0b13.html", "source_name": "Stock Titan", "published_at": "2026-06-22T22:10:28", "published_display": "22 Jun 2026 22:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GeoVax Labs (GOVX) director gets grant of 6,000 stock options", "summary": "GeoVax Labs director Dean G. Kollintzas was granted 6,000 stock options on June 17, 2026. These options have an exercise price of $1.18 per share and expire on June 17, 2036. This transaction is categorized as a compensation-related award, not a market purchase, increasing his de", "url": "https://www.stocktitan.net/sec-filings/GOVX/form-4-geo-vax-labs-inc-insider-trading-activity-1892f0278ead.html", "source_name": "Stock Titan", "published_at": "2026-06-22T21:40:33", "published_display": "22 Jun 2026 21:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GeoVax (GOVX) CEO David Dodd granted 29,300 stock options at $1.18 strike", "summary": "GeoVax Labs, Inc. President and CEO David A. Dodd was granted 29,300 stock options with an exercise price of $1.18 per share. These options, which expire on June 17, 2036, will vest in three equal annual installments on the first three anniversaries of the grant date. This transa", "url": "https://www.stocktitan.net/sec-filings/GOVX/form-4-geo-vax-labs-inc-insider-trading-activity-8ba1ccfcda57.html", "source_name": "Stock Titan", "published_at": "2026-06-22T20:10:09", "published_display": "22 Jun 2026 20:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GeoVax Labs (GOVX) VP receives grant of 17,600 stock options", "summary": "GeoVax Labs, Inc. (GOVX) VP of Business Development, John W. Sharkey, received a grant of 17,600 stock options on June 17, 2026. These options have an exercise price of $1.18 per share and will vest in three equal annual installments, expiring on June 17, 2036. This transaction i", "url": "https://www.stocktitan.net/sec-filings/GOVX/form-4-geo-vax-labs-inc-insider-trading-activity-c9a631603814.html", "source_name": "Stock Titan", "published_at": "2026-06-22T20:10:09", "published_display": "22 Jun 2026 20:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Director at GeoVax Labs (NASDAQ: GOVX) granted 6,000 options", "summary": "GeoVax Labs director Nicole Lemerond was granted 6,000 stock options, which allow her to purchase common stock at an exercise price of $1.18 per share, with an expiration date of June 17, 2036. This transaction is classified as a routine equity compensation award, not an open-mar", "url": "https://www.stocktitan.net/sec-filings/GOVX/form-4-geo-vax-labs-inc-insider-trading-activity-e22db6dea669.html", "source_name": "Stock Titan", "published_at": "2026-06-22T20:10:09", "published_display": "22 Jun 2026 20:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GeoVax Labs Inc (GOVX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "This article from TradingKey attempts to provide a revenue breakdown for GeoVax Labs Inc (GOVX) by business segments and regions. However, it explicitly states that the relevant financial data has not yet been disclosed by the company, making a detailed analysis impossible at thi", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-govx/revenue", "source_name": "TradingKey", "published_at": "2026-06-18T19:39:49", "published_display": "18 Jun 2026 19:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GeoVax Labs Inc (GOVX) Institutional Confidence", "summary": "This article provides an overview of institutional confidence in GeoVax Labs Inc (GOVX), highlighting key shareholders and their holdings. The company's stock information, including its recent price and market capitalization, is also presented, alongside a breakdown of various fi", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-govx/sentiment", "source_name": "TradingKey", "published_at": "2026-06-18T19:39:48", "published_display": "18 Jun 2026 19:39", "sentiment": "positive", "sentiment_pct": 77, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GeoVax Labs Inc (GOVX) Shareholder Structure: Major Shareholders & Institutional Holdings", "summary": "This article provides an overview of GeoVax Labs Inc.'s (GOVX) shareholder structure, detailing major institutional shareholders and their holdings. It lists top shareholders like Citadel Advisors LLC and Renaissance Technologies LLC, along with various shareholder types and thei", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-govx/ownership", "source_name": "TradingKey", "published_at": "2026-06-18T03:09:20", "published_display": "18 Jun 2026 03:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GeoVax Labs Inc (GOVX) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "This article provides an overview of GeoVax Labs Inc (GOVX) dividend and stock split history. It notes that the company has distributed $0.00 in dividends over the past five years and lists several stock merger events from January 2024 and one scheduled for January 2026. The data", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-govx/dividend-splits", "source_name": "TradingKey", "published_at": "2026-06-18T02:09:19", "published_display": "18 Jun 2026 02:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GeoVax Labs Inc (GOVX) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "GeoVax Labs Inc (GOVX) has an earnings forecast score of 7.33, ranking 295th in its industry. Analysts have set an average price target of $8.50, with a consensus \"Buy\" rating based on two analysts. The company's EPS for the last quarter was -$2.55, better than the market expecta", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-govx/earnings", "source_name": "TradingKey", "published_at": "2026-06-17T20:09:20", "published_display": "17 Jun 2026 20:09", "sentiment": "positive", "sentiment_pct": 72, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GeoVax Labs (GOVX) shareholders approve major warrant share issuances and governance items", "summary": "GeoVax Labs shareholders have approved several key items at their recent annual meeting, including the election of seven directors, ratification of Wipfli LLP as the independent auditor for 2026, and advisory approval of executive compensation with future say-on-pay votes every t", "url": "https://www.stocktitan.net/sec-filings/GOVX/8-k-geo-vax-labs-inc-reports-material-event-58711287cf03.html", "source_name": "Stock Titan", "published_at": "2026-06-17T20:09:19", "published_display": "17 Jun 2026 20:09", "sentiment": "negative", "sentiment_pct": 30, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GeoVax Highlights Strategic Implications of Recent Gedeptin(R) Findings for Checkpoint-Resistant Cancers", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/geovax-highlights-strategic-implications-recent-130000583.html", "source_name": "NewMediaWire", "published_at": "2026-06-17T13:00:00+00:00", "published_display": "17 Jun 2026 13:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GeoVax Labs Inc (GOVXW) Institutional Confidence", "summary": "This article provides details on the institutional confidence for GeoVax Labs Inc (GOVXW), focusing on institutional shareholding and shareholder activity. It lists UBS Financial Services, Inc. and Clear Street LLC as notable shareholders with their respective shares held and per", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-govxw/sentiment", "source_name": "TradingKey", "published_at": "2026-06-17T09:40:35", "published_display": "17 Jun 2026 09:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GeoVax Labs (GOVX) Could Find a Support Soon, Here's Why You Should Buy the Stock Now", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxQUnV6cFZGSk9MZFg5WjhTdkdyRWNHdXhQel9qZmtCbVROYkljaUNXbDYtX05mZGdrSDJBdFhFdDlxOTFEcmJ6QkhMVzhfbFlEbG1XdzdYRlpOSHlPV2t3VlBJU3VMRVlIbklSRE5haGJVekhJRnI0NzJIaGdVcmc1LUdPbkpLTGNFLUxaSE9ZdndXeTB5ekFNYVhlcw?oc=5", "source_name": "Market source", "published_at": "2026-06-12T07:00:00+00:00", "published_display": "12 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GeoVax Highlights Peer-Reviewed Research Supporting Gedeptin(R) Potential to Enhance Cancer Immunotherapy Responses", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/geovax-highlights-peer-reviewed-research-130000933.html", "source_name": "NewMediaWire", "published_at": "2026-06-08T13:00:00+00:00", "published_display": "08 Jun 2026 13:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GeoVax CEO Highlights Renewed Strategic Interest in Vaccine Platforms and Infectious Disease Innovation", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/geovax-ceo-highlights-renewed-strategic-130000780.html", "source_name": "NewMediaWire", "published_at": "2026-06-03T13:00:00+00:00", "published_display": "03 Jun 2026 13:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GeoVax CEO Welcomes FIFA World Cup 2026 While Addressing Biothreat Readiness", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/geovax-ceo-welcomes-fifa-world-131500641.html", "source_name": "NewMediaWire", "published_at": "2026-06-01T13:15:00+00:00", "published_display": "01 Jun 2026 13:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How The GeoVax Labs (GOVX) Story Is Shifting With Vaccine Progress And Funding Risks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOSHVULTdZVTQ2YkNUMUluYWtIdEdMSGwtQTFUbkg4bEpQWXdaa0dVMG5qOVVSWndEazZLbmh0WlliejhodlhwZnA3RmwxckFNUVhwSXZBQmQ4MW9xcUFZaW9VQXhlREpUY1JYdzhTOGc1VTlnQlVYMk00WDB5dGFVb0VZMUpMNWhCeEtDS1BMX25tbnEtTGpSVDl3U1g?oc=5", "source_name": "Market source", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GeoVax (NASDAQ: GOVX) prices $3M warrant-based private financing", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxNdEFQdVBYQXQ0NWNpeDhWYzBfNUllUndiQzhDcm9VMU9DU0NVdTdVczdaQjdMRUdBdmV5UGMzSFVPN1hCUFdiRTNEWjBiQVllZTBoblduN3ZlMVFzakFSWHVxMkJmV1c3SzB0M1FJMzZrVlR6UnJGVnVRVDVvanpPTW55bGRxZTZsV0xJekNOSWktTW54dFZ1SzlkeFg0NGN0bGZRc2RvX1c?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-19T07:00:00+00:00", "published_display": "19 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Is GeoVax Labs Stock Falling Tuesday?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxPcmZFNllrOEd0T2l5dEJaSG0wandOc0EzaEloekRENEhsUFNsS25JbWx5Ti12MlhmMWgxVmI3T0pXTjZmcmRkODhObFhnZU5OazZaQnFDUmIzOXdBZHNST19QdTVmUXVNNmdQT2h2TVp3NEhKM0ZXZk1mWGpfQ2xtR2hrMXlIeXF3dkdRWDZRZndKalRIQS1EQWY3ZTczYUVfR0g4?oc=5", "source_name": "Benzinga", "published_at": "2026-05-19T07:00:00+00:00", "published_display": "19 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GeoVax Announces $3 Million Private Placement Financing Priced At-the-Market Under Nasdaq Rules", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNMndZdlVjMjd6ZjNFRFhyWklxNlJibDRTTXFIQzBvU0VpX1BQdXV5VGVOcmMxaWpqcnFPdm9DRVQxWWphNzU2SHVkVDVBOHRYS1kwNDJqcDI1VG41cHl1MnpSRVY4alB2aFVkMGdKM1daS3hMbFNuUWpYTldDQnJIeHRwMU9FQmRWY0o1VDVNdExtYkpicU1uMzRxc0VuYVhzUXFGbmFR?oc=5", "source_name": "Market source", "published_at": "2026-05-18T07:00:00+00:00", "published_display": "18 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GeoVax Labs (GOVX) jumps 178% as traders refocus on mpox vaccine thesis after recent Q1 update", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxNZzYwTmFiYi1BSjJrb0hTSi0xNUhWZG9kb1UyMVJ4TDJadkVTZXNJelhuTTRGYWlSWmFMdVFZYXlEclduZ0toVDRLdEpPMUk4ZGhMZ3E5REJTZjF5T0V4UkFOTW5iX1IwVzRFakJLeHFsVllQalp0WjRpTFp4TUFWbHdjaFpGaU5CNllpdV9NRU9yWUw0eDFzaDdISFVGcUNaV3pKbWtVMFdXTWE3ODR2YnVOOS1fNGY5T1V2TWVFb1pwWEstajVlTkwyUUJUZw?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-05-18T07:00:00+00:00", "published_display": "18 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "All You Need to Know About GeoVax Labs (GOVX) Rating Upgrade to Buy", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxOQWZEcHlNSGhKeWZRcTFrLUI4VVBNdWM3R0JaMkwxTjAzVzBJUXE2UU8yMnJqTVNjb091SzBpX2ZsSnk2MkJPdVU2YVAzQWloZGF1VUU1RGtlczZzcWRESmEtaDl2ekJmOVFaanpRMldTcHlMblVfVG96d3dnWkRLSEI0RmRIcW9MMWV5SFRNOGFCX04yOHBQZg?oc=5", "source_name": "Market source", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GeoVax Announces a Warrant Inducement Transaction", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxOQldhNkJWUTZudzRkWjhGaUd3YXFkalR0TE4wcF9WR2FkSnl4Q2NoemRqZnBqOVEyRGZGMF9nNktKRzlHWXdJbWFHMHdYU09qejdNSlBEemFJRGFkampNQmc2czlSRjNUVnB2dEZ0czdWbF9BR0c0UnFqbi1sankySmcyRGpPdzhSSEgzbFh1QWtXZHRha3FJdDZlOGNfQVIxRG9KSGdleUkzMS15Nnp6U1NkMEtYTFU?oc=5", "source_name": "Market source", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How The GeoVax Labs (GOVX) Story Is Shifting After The Rating Downgrade And Valuation Reset", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxNNFViVGlvY21mbHJFSV9RWGFqdUVFODBNSVV4SHNiLWZHMkJrQmgzeUhUWWZ3S1hObVpEMnNHT214LUVZZTdaR1FTRFZTanNoN3E0MVk1Snk3MlE0RndoN3FyUDdmd1haaTBROThiQ3N2bDl0aTJ1dzVjQlk4OGtBUWRCd1BobllPSXZTSm9rWVNDTlQ0bkp4eldnQVE?oc=5", "source_name": "Market source", "published_at": "2026-04-14T07:00:00+00:00", "published_display": "14 Apr 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why The GeoVax Labs (GOVX) Story Is Shifting As Valuation Holds And Risks Rise", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxOdGFTS1U5dzFPUHd4VlJaeDYtQzVFaUlYa1pCTW1MQkFNdlJFeWxYeTIxMjBQWmVDWlMyZzNvQ3dyWTVxY3JueW5vdXRnUnNSbkF6bE1XZzUybXl3Z01kNzJUZy1SN0VKUUQ5MDZaUGdDbTJmcmNUTG1UdGp4dUY0RUJ0RkliVXdfbXdPY2dHS0tSZUxoY3c?oc=5", "source_name": "Market source", "published_at": "2026-03-31T07:00:00+00:00", "published_display": "31 Mar 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How The Story On GeoVax Labs (GOVX) Is Shifting Toward Execution Risk And Funding Constraints", "summary": "", "url": "https://news.google.com/rss/articles/CBMigwFBVV95cUxPX1BJcWJCclFDaGhwRXFKY1RfOXU5YjBfZHhFbHhReXE1c0NkTGEyVzZDR29fRmlpVXRBZGFOcEx5N09XU09HRmhUclhrdXZOZkZ1bXZTUDdRUHQtVmZ4UFQtOE1WMHhoOWN0NHBvOFIwaUNHOUNYbFVvT2xXcU0zcXJBOA?oc=5", "source_name": "Market source", "published_at": "2026-03-11T07:00:00+00:00", "published_display": "11 Mar 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GeoVax Announces 1-for-25 Reverse Stock Split to Regain Compliance With Nasdaq Minimum Bid Requirement", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxQVFFHUVNhWjhscjlZNEFoY2Jra0tmM3ItZVhrRDhJUFBObW9rZEFXLW1aS3VvR1l2SFpXWXpLOHRKRk5tN1JuSHNYWE80MFZ3cWhnWXJDRFdFVUVBd3ZFR2oyUVV1UGlSU1BoM2ZieGE3T3h2bjZfOEtRX0V1Y1hfQQ?oc=5", "source_name": "Market source", "published_at": "2026-01-08T08:00:00+00:00", "published_display": "08 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GeoVax Labs, Inc. (GOVX) Stock Price Quote Today & Current Price Chart", "summary": "", "url": "https://news.google.com/rss/articles/CBMie0FVX3lxTE1SUHBETm9JLVpTSHVpLXBlTFdNcGJDR1hjemZkNHNJMXllVXVOdW5PNXdHSU0tUFpMRGxtR18tcnEwM0lkZkJ1MTVPLXZaNmhDNXh3LXVIZWFka3dwem5SU2EyV1cxVDJYaVVRQ0k2dWJwNmc3YnBYSjNnQQ?oc=5", "source_name": "Capital.com", "published_at": "2025-11-13T06:11:30+00:00", "published_display": "13 Nov 2025 06:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Geovax Labs (GOVX) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE1BS01TYVUtZ09DSktOZlZsSC12MGo4MFpna3V3VjdOMUVvZlp5U29lUjJxYTI0MzZnaEkwQXh3aFcxeURUbjlUUTl6YUh2WWJpbHl3?oc=5", "source_name": "Stock Titan", "published_at": "2025-04-25T00:20:37+00:00", "published_display": "25 Apr 2025 00:20", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Geovax Labs (GOVXW) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiVEFVX3lxTE1LZGxVZkhvLThmNHFsZU54MHp0R253TW41d3V0N1dIRUZSRE83dVdfaUtfV0NQSmhZUENzMDF6YmZ4VW10bGdET0FHajQ1bGlpV01mTw?oc=5", "source_name": "Stock Titan", "published_at": "2025-04-25T00:19:17+00:00", "published_display": "25 Apr 2025 00:19", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GeoVax Labs, Inc. (GOVX): A Hot Penny Stock On The Move", "summary": "", "url": "https://news.google.com/rss/articles/CBMiekFVX3lxTE5jUy0wcnBfWURUMk9KU0pJWm5ZZk9rQkdYM2hfVTBfZTFNMzJOQ3l4YU5JWGI5VFlvaXlxTWRGdXJNLXdKYV9OWWNGTTB1TWowR21aa254SU1DS2NuTDltWjRvYmhHUWNndWVFX3hWREhVM0w4QkpxNnhn?oc=5", "source_name": "Market source", "published_at": "2024-09-03T07:00:00+00:00", "published_display": "03 Sep 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNYmZ3aHMyMjBuNmlEUGN6NWZBZV85cEFWNndJaVNoNEVYNk84MlNKRXJ0RXpRQl9wN1RsekhxM3loY1RRNDJhTnVremtReHhLQWVHS053VzRBUTduSkdqRGt1YkxMMThqZHoydElPX1Zfd3hEMi15VlRwRGRvZ2JqRDFneVVxN0JCYzQ4QlV5TTBEOWx3?oc=5", "source_name": "Market source", "published_at": "2026-07-16T18:49:22+00:00", "published_display": "16 Jul 2026 18:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T07:00:00+00:00", "published_display": "13 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 99, "total_relevant": 61, "sentiment_summary": {"positive": 6, "negative": 10, "neutral": 45, "score": 49, "total": 61, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 85, "events": [{"event": "general", "label": "Market update", "weight": 23.1, "count": 42}, {"event": "earnings", "label": "Earnings", "weight": 5.91, "count": 13}, {"event": "deals", "label": "Deals and strategy", "weight": 1.1, "count": 2}, {"event": "analyst", "label": "Analyst action", "weight": 1.1, "count": 2}, {"event": "guidance", "label": "Guidance", "weight": 0.55, "count": 1}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 0.55, "count": 1}], "positive_events": 6, "negative_events": 10}, "market_context": {"has_market_context": true, "latest_close": 0.97, "latest_week": "2026-07-17", "one_week_move": -17.4, "four_week_move": -27.3, "twelve_week_move": -10.6, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 1.20156, "market_dynamics_buy_signal": false, "relative_strength": -88.46336, "fair_value_gap": -98.3, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 35.8265, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-17.4% over one week, -27.3% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 61, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 18}, {"label": "Stock Titan", "count": 15}, {"label": "TradingKey", "count": 6}, {"label": "NewMediaWire", "count": 5}, {"label": "TradingView", "count": 5}, {"label": "Moomoo", "count": 3}, {"label": "simplywall.st", "count": 2}, {"label": "The Globe and Mail", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 52}, {"label": "Industry context", "count": 9}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 42}, {"label": "Earnings", "count": 13}, {"label": "Deals and strategy", "count": 2}, {"label": "Analyst action", "count": 2}, {"label": "Guidance", "count": 1}, {"label": "Regulatory and legal", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "49/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "85/100 classification confidence."}, {"label": "Company focus", "value": "52", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-17.4% over one week, -27.3% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "GeoVax Highlights Strategic Alignment of GEO-MVA With HHS/ASPR's Five-Year Medical Countermeasure Preparedness Strategy"}], "updated_at": "2026-07-22T02:48:02.845447+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}